期刊
JOURNAL OF CROHNS & COLITIS
卷 8, 期 10, 页码 1147-1165出版社
OXFORD UNIV PRESS
DOI: 10.1016/j.crohns.2014.03.008
关键词
Inflammatory bowel disease; Ulcerative colitis; Crohn's disease; Intestinal fibrosis; Microbiota; Genetics
资金
- Alfa Wassermann
- Sofar
- Abbot
- Ardeypharm
- Essex/MSD
- FALK
- Flamentera
- Novartis
- Roche
- Tillots
- UCB
- Zeller
- AbbVie
The fourth scientific workshop of the European Crohn's and Colitis Organization (ECCO) focused on the relevance of intestinal fibrosis in the disease course of inflammatory bowel disease (IBD). The objective was to better understand the pathophysiological mechanisms of intestinal fibrosis, to identify useful markers and imaging modalities of fibrosis in order to assess its presence and progression, and, finally, to point out possible approaches for the prevention and the treatment of fibrosis. The results of this workshop are presented in three separate manuscripts. This first section describes the most important mechanisms that contribute to the initiation and progression of intestinal fibrosis in IBD including the cellular and molecular mediators, the extracellular matrix molecules and matrix metalloproteinases/tissue inhibitors of metalloproteinases-system, the microbiota products, the role of fat, genetic and epigenetic factors, as well as the currently available experimental models. Furthermore, it identifies unanswered questions in the field of intestinal fibrosis and provides a framework for future research. (C) 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据